Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) (Record no. 9562714)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01640 a2200493 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513143109.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199806s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0028-3878 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1212/wnl.50.5.1266 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Rudick, R A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19980608 |
245 00 - TITLE STATEMENT | |
Title | Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Neurology |
Date of publication, distribution, etc. | May 1998 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1266-72 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigen-Antibody Reactions |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interferon beta-1a |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interferon-beta |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Multiple Sclerosis |
General subdivision | drug therapy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Simonian, N A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Alam, J A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Campion, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Scaramucci, J O |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jones, W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Coats, M E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Goodkin, D E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Weinstock-Guttman, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Herndon, R M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mass, M K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Richert, J R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Salazar, A M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Munschauer, F E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cookfair, D L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Simon, J H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jacobs, L D |
773 0# - HOST ITEM ENTRY | |
Title | Neurology |
Related parts | vol. 50 |
-- | no. 5 |
-- | p. 1266-72 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1212/wnl.50.5.1266">https://doi.org/10.1212/wnl.50.5.1266</a> |
Public note | Available from publisher's website |
No items available.